Innovotech (TSXV:IOT) EBITDA Margin %: -51.54% (As of Mar. 2026)


What is Innovotech EBITDA Margin %?

Innovotech TSXV:IOT EBITDA Margin % is -51.54% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 942 Biotechnology companies, Innovotech ranks better than 65.18% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innovotech's EBITDA for the three months ended in Mar. 2026 was C$-0.33 Mil. Innovotech's Revenue for the three months ended in Mar. 2026 was C$0.65 Mil. Therefore, Innovotech's EBITDA margin for the quarter that ended in Mar. 2026 was -51.54%.

Innovotech  (TSXV:IOT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Innovotech EBITDA Margin % Related Terms

Innovotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Innovotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovotech EBITDA Margin % Chart

Innovotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.82 -1.51 -6.68 13.04 5.82

Innovotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.89 -18.50 9.78 19.47 -51.54

TSXV:IOT vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Innovotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovotech EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innovotech's EBITDA Margin % falls into.


Innovotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innovotech's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.264/4.535
=5.82 %

Innovotech's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.334/0.648
=-51.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -51.54% mean?
Innovotech (TSXV:IOT) has a EBITDA Margin % of -51.54% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovotech and its competitors. According to the industry distribution chart, Innovotech ranks #328 out of 942 companies in the Biotechnology industry, placing it in the top 34.8%.
Is Innovotech's EBITDA Margin % too high?
Innovotech's current EBITDA Margin % is -51.54%. Based on the distribution chart, Innovotech ranks #328 out of 942 companies in the Biotechnology industry, which is above the industry midpoint.
How does Innovotech's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Innovotech ranks #328 out of 942 companies for EBITDA Margin %. This puts Innovotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Innovotech and its competitors. Innovotech's current EBITDA Margin % is -51.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovotech stock overvalued right now?
Based on GuruFocus' analysis, Innovotech (TSXV:IOT) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.27, compared to a current price of C$0.10 — trading 63% below its estimated fair value. The current EBITDA Margin % is -51.54%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Innovotech (TSXV:IOT), the current EBITDA Margin % is -51.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovotech Business Description

Address 2011 - 94 Street, Suite C203, Edmonton, AB, CAN, T6N 1H1
Innovotech Inc is a Canada-based company that provides solutions to clients' biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The operating segments of the company include Innovotech and Keystone. Geographically, the firm has a business presence in the United States, Canada, and International, with the majority of the revenue derived from the United States.